The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Open accessAbstract
Although CRISPR-Cas9 nucleases are widely used for genome editing, the range of sequences that Cas9 can recognize is constrained by the need for a specific protospacer adjacent motif (PAM). As a result, it can often be difficult to target double-stranded breaks (DSBs) with the precision that is necessary for various genome-editing applications. The ability to engineer Cas9 derivatives with purposefully altered PAM specificities would address this limitation. Here we show that the commonly used Streptococcus pyogenes Cas9 (SpCas9) can be modified to recognize alternative PAM sequences using structural information, bacterial selection-based directed evolution, and combinatorial design. These altered PAM specificity variants enable robust editing of endogenous gene sites in zebrafish and human cells not currently targetable by wild-type SpCas9, and their genome-wide specificities are comparable to wild-type SpCas9 as judged by GUIDE-seq analysis. In addition, we identify and characterize another SpCas9 variant that exhibits improved specificity in human cells, possessing better discrimination against off-target sites with non-canonical NAG and NGA PAMs and/or mismatched spacers. We also find that two smaller-size Cas9 orthologues, Streptococcus thermophilus Cas9 (St1Cas9) and Staphylococcus aureus Cas9 (SaCas9), function efficiently in the bacterial selection systems and in human cells, suggesting that our engineering strategies could be extended to Cas9s from other species. Our findings provide broadly useful SpCas9 variants and, more importantly, establish the feasibility of engineering a wide range of Cas9s with altered and improved PAM specificities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Precision editing of alleles in a human cell has drastically improved the understanding of genotypic and phenotypic effects in gene therapy due to the lower off-target rates [119,120,121].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides, there are other variants that could identify different PAM sequences, such as VQR, VRER, VRQR, and QQR1, allowing gene editing on a wider range of genetic loci.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The basic bacterial selection scheme performed was adapted from a previously described positive selection system for identifying Cas9 mutants in E. coli31.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“To be applicable to a wider range of genomic sites, some non-NGG PAM Cas9 were generated.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“This could result in the development of wider-ranged VQR, EQR, and VRER SpCas9 variants, enabling the targeting of NGAN, NGNG, and NGCG PAMs, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“These modifications have led to the creation of SpCas9 variants such as VQR, EQR, and VRER, which can recognize broader PAM sequences like NGAN, NGNG, and NGCG, respectively (Kleinstiver et al., 2015; Hirano et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Kleinstiver et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This screen identified four key beneficial point mutations in SpCas9, giving rise to evoCas9, a variant that exhibits fidelity exceeding SpCas9-HF1 and eSpCas9 (Kleinstiver et al., 2015; Casini et al., 2018).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Kleinstiver et al., 2015
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“SaKKHcas9 is an evolved variant of SaCas9 and recognizes the more relaxed NNNRRT PAM18.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Self-citationCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,001
Exploiting the CRISPR/Cas9 PAM Constraint for Single-Nucleotide Resolution Interventions
Li, Y., Mendiratta, S., Ehrhardt, K., Kashyap, N., White, M. A., & Bleris, L. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144970 · Cited by 31
CRISPR-Cas nucleases and base editors for plant genome editing
Gürel, F., Zhang, Y., Sretenovic, S., & Qi, Y. (2019) · aBIOTECH · doi:10.1007/s42994-019-00010-0 · Cited by 33
Synthetic chimeric nucleases function for efficient genome editing
Liu, R., Liang, L., Freed, E. F., Chang, H., Oh, E. J., Liu, Z., Garst, A. D., Eckert, C. A., & Gill, R. T. (2019) · Nature Communications · doi:10.1038/s41467-019-13500-y · Cited by 33
Genome and base editing for genetic hearing loss
Niggemann, P., György, B., & Chen, Z. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107958 · Cited by 32
Gene Therapy for Inherited Retinal Degeneration
Arbabi, A., Liu, A., & Ameri, H. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0087 · Cited by 30
Ham, D. T., Browne, T. S., Banglorewala, P. N., Wilson, T. L., Michael, R. K., Gloor, G. B., & Edgell, D. R. (2023) · Nature Communications · doi:10.1038/s41467-023-41143-7 · Cited by 33
The Interface of Gene Editing with Regenerative Medicine
Farag, V., Devey, E. A., & Leong, K. W. (2024) · Engineering · doi:10.1016/j.eng.2024.10.019 · Cited by 30
Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing
Shi, H., Al-Sayyad, N., Wasko, K. M., Trinidad, M. I., Doherty, E., Vohra, K., Boger, R. S., Colognori, D., Cofsky, J. C., Skopintsev, P., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.03.024 · Cited by 32
Tang, S., Chen, X., Tong, X., & Zhu, L. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.112724 · Cited by 31
Engineered probiotics: a new era in treating inflammatory bowel disease
Duan, S., Wang, Y., Zhan, S., Ye, Z., Luo, T., Zhou, Y., Xu, H., & Huang, H. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07271-y · Cited by 30
The Rise of CRISPR/Cas for Genome Editing in Stem Cells
Shui, B., Hernández-Matías, L., Guo, Y., & Peng, Y. (2016) · Stem Cells International · doi:10.1155/2016/8140168 · Cited by 33
Genetically engineered mouse models for studying radiation biology
Castle, K. D., Chen, M., Wisdom, A. J., & Kirsch, D. G. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.06.19 · Cited by 32
Näsvall, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184126 · Cited by 30
Yue, M., & Ogawa, Y. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1227 · Cited by 30
Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
Bolukbasi, M. F., Liu, P., Luk, K., Kwok, S. F., Gupta, A., Amrani, N., Sontheimer, E. J., Zhu, L. J., & Wolfe, S. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07310-x · Cited by 30
Li, J.-J., Lin, X., Tang, C., Lu, Y., Hu, X., Zuo, E., Li, H., Ying, W., Sun, Y., Lai, L., et al. (2019) · National Science Review · doi:10.1093/nsr/nwz131 · Cited by 31
CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss
Farooq, R., Hussain, K., Tariq, M., Farooq, A., & Mustafa, M. (2020) · Journal of Applied Genetics · doi:10.1007/s13353-019-00535-6 · Cited by 30
Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review)
Alagöz, M., & Kherad, N. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4609 · Cited by 32
High-throughput genetic engineering tools for regulating gene expression in a microbial cell factory
Yeom, J., Park, J. S., Jung, S.-W., Lee, S., Kwon, H.-J., & Yoo, S. M. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2021.2007351 · Cited by 30
Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease
Chen, W., Zhang, H., Zhang, Y., Wang, Y., Gan, J., & Ji, Q. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000496 · Cited by 31
Genome Editing Strategies Towards Enhancement of Rice Disease Resistance
Mishra, R., Zheng, W., Joshi, R. K., & Zhao, K. (2021) · Rice Science · doi:10.1016/j.rsci.2021.01.003 · Cited by 30
He, Y., Han, Y., Ma, Y., Liu, S., Fan, T., Liang, Y., Tang, X., Zheng, X., Wu, Y., Zhang, T., et al. (2024) · Plant Biotechnology Journal · doi:10.1111/pbi.14363 · Cited by 29
Graph theory approaches for molecular dynamics simulations
Patel, A. C., Sinha, S., & Palermo, G. (2024) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583524000143 · Cited by 33
Engineering a New Generation of Gene Editors: Integrating Synthetic Biology and AI Innovations
Chia, B. S., Seah, S., Wang, B., Shen, K., Srivastava, D., & Chew, W. L. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00686 · Cited by 31
Liu, Q., Zhou, J., Li, S., Li, Y., Wan, Y., Hu, Z., Ma, S., Zou, Z., & Yang, R. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf287 · Cited by 29
The therapeutic landscape of HIV-1 via genome editing
Kwarteng, A., Ahuno, S. T., & Kwakye-Nuako, G. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0157-8 · Cited by 31
Molecular tools for pathway engineering in Saccharomyces cerevisiae
Besada‐Lombana, P. B., McTaggart, T. L., & Silva, N. A. D. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.12.002 · Cited by 34
Production of CRISPR/Cas9-Mediated Self-Cleaving Helper-Dependent Adenoviruses
Palmer, D. J., Turner, D. L., & Ng, P. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.04.003 · Cited by 30
CRISPR Diagnosis and Therapeutics with Single Base Pair Precision
Lee, S. H., Park, Y., Jin, Y. B., Kim, S., & Hur, J. K. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.008 · Cited by 29
Genome Editing as A Versatile Tool to Improve Horticultural Crop Qualities
Chen, Y., Mao, W., Liu, T., Feng, Q., Li, L., & Li, B. (2020) · Horticultural Plant Journal · doi:10.1016/j.hpj.2020.11.004 · Cited by 29
History, evolution and classification of CRISPR-Cas associated systems
Agarwal, N., & Gupta, R. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.012 · Cited by 29
Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
Yang, Y.-C., & Yang, H. (2021) · Viruses · doi:10.3390/v14010004 · Cited by 31
Brooks, D. L., Whittaker, M. N., Said, H., Dwivedi, G., Qü, P., Musunuru, K., Ahrens‐Nicklas, R. C., Alameh, M., & Wang, X. (2023) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2023.100253 · Cited by 33
Gene editing and its application for hematological diseases
Osborn, M. J., Belanto, J. J., Tolar, J., & Voytas, D. F. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2017-z · Cited by 32
Gene therapy for inherited retinal degenerations: initial successes and future challenges
Gupta, P. R., & Huckfeldt, R. M. (2017) · Journal of Neural Engineering · doi:10.1088/1741-2552/aa7a27 · Cited by 32
CRISPys: Optimal sgRNA Design for Editing Multiple Members of a Gene Family Using the CRISPR System
Hyams, G., Abadi, S., Lahav, S., Avni, A., Halperin, E., Shani, E., & Mayrose, I. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.03.019 · Cited by 31
Applying the auxin-inducible degradation system for rapid protein depletion in mammalian cells
Lambrus, B. G., Moyer, T. C., & Holland, A. J. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.03.004 · Cited by 31
Rabinowitz, R., Almog, S., Darnell, R., & Offen, D. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00851 · Cited by 29
CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders
Cabré-Romans, J.-J., & Cuella-Martin, R. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1553590 · Cited by 33
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 31
Naert, T., Nieuwenhuysen, T. V., & Vleminckx, K. (2017) · genesis · doi:10.1002/dvg.23005 · Cited by 28
Production of knock-in mice in a single generation from embryonic stem cells
Ukai, H., Kiyonari, H., & Ueda, H. R. (2017) · Nature Protocols · doi:10.1038/nprot.2017.110 · Cited by 28
Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9
Liu, Z., Chen, S., Xie, W., Song, Y., Li, J., Lai, L., & Li, Z. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.013 · Cited by 29
Self-citationGenome editing with type II‐C CRISPR‐Cas9 systems from Neisseria meningitidis in rice
Xu, R., Qin, R., Xie, H., Li, J., Liu, X., Zhu, M., Sun, Y., Yu, Y., Lu, P., & Wei, P. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13716 · Cited by 29
The heat is on: a simple method to increase genome editing efficiency in plants
Blomme, J., Develtere, W., Köse, A., Ribera, J. A., Brugmans, C., Jaraba-Wallace, J., Decaestecker, W., Rombaut, D., Baekelandt, A., Fernández-Fernández, Á. D., et al. (2022) · BMC Plant Biology · doi:10.1186/s12870-022-03519-7 · Cited by 28
Sun, R., Zhao, Y., Wang, W., Liu, J., & Chen, C. (2023) · Chemical Science · doi:10.1039/d2sc05463a · Cited by 28
Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9
Park, C., Sung, J. J., Choi, S.-H., Lee, D. R., Park, I., & Kim, D. (2016) · Nature Protocols · doi:10.1038/nprot.2016.129 · Cited by 28
The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9
Tsui, T. K. M., Hand, T. H., Duboy, E. C., & Li, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00050 · Cited by 28
Ando, K., Shah, A. K., Sachdev, V., Kleinstiver, B. P., Taylor‐Parker, J., Welch, M. M., Hu, Y., Salgia, R., White, F. M., Parvin, J. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16376 · Cited by 28
Self-citationCRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells
Kramarzová, K. Š., Osborn, M. J., Webber, B. R., DeFeo, A. P., McElroy, A. N., Kim, C. A., & Tolar, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061269 · Cited by 28
Programmable Single and Multiplex Base-Editing in Bombyx mori Using RNA-Guided Cytidine Deaminases
Li, Y., Ma, S., Sun, L., Zhang, T., Chang, J., Lü, W., Chen, X., Liu, Y., Wang, X., Shi, R., et al. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200134 · Cited by 28
Gene editing prospects for treating inherited retinal diseases
Benati, D., Patrizi, C., & Recchia, A. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106473 · Cited by 28
Mekler, V. M., Kuznedelov, K. D., & Severinov, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012239 · Cited by 29
Bzhilyanskaya, V., Ma, L., Liu, S., Fox, L. R., Whittaker, M. N., Meis, R. J., Choi, U., Lawson, A., Ma, M., Theobald, N., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj6779 · Cited by 27
Self-citationPrime Editing: A Revolutionary Technology for Precise Treatment of Genetic Disorders
Li, M., Lin, Y., Cheng, Q., & Wei, T. (2025) · Cell Proliferation · doi:10.1111/cpr.13808 · Cited by 28
The zebrafish genome editing toolkit
Ata, H., Clark, K. J., & Ekker, S. C. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2016.04.023 · Cited by 30
The Yin and Yang of nucleic acid-based therapy in the brain
Gustincich, S., Zucchelli, S., & Mallamaci, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.001 · Cited by 27
Genomic and proteomic biases inform metabolic engineering strategies for anaerobic fungi
Wilken, S. E., Seppälä, S., Lankiewicz, T. S., Saxena, M., Henske, J. K., Salamov, A. A., Grigoriev, I. V., & O’Malley, M. (2019) · Metabolic Engineering Communications · doi:10.1016/j.mec.2019.e00107 · Cited by 28
Christie, K. A., Robertson, L. J., Conway, C., Blighe, K., DeDionisio, L., Chao-Shern, C., Kowalczyk, A. M., Marshall, J., Turnbull, D. M., Nesbit, M. A., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.05.002 · Cited by 27
Yu, S.-Y., Carlaw, T., Thomson, T., Birkenshaw, A., Basha, G., Kurek, D. Z., Huang, C., Kulkarni, J. A., Zhang, L., & Ross, C. J. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.009 · Cited by 27
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
Zhou, L., & Yao, S. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00115-5 · Cited by 29
HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
Zhao, C., Zhao, Y., Zhang, J., Lu, J. Q., Chen, L., Zhang, Y., Yue, Y., Xu, J., Wei, S., & Wang, Y. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.08.022 · Cited by 27
Pieczynski, J. N., Deets, A., McDuffee, A., & Kee, H. L. (2019) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.21206 · Cited by 27
Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
Dai, X., Blancafort, P., Wang, P., Sgro, A., Thompson, E. W., & Ostrikov, K. (2020) · Advanced Science · doi:10.1002/advs.201902552 · Cited by 28
CRISPR Editing in Biological and Biomedical Investigation
Ju, X., Xu, J., & Sun, Z. S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26154 · Cited by 27
Li, J., Wu, P., Cao, Z., Huang, G., Lu, Z., Yan, J., Zhang, H., Zhou, Y., Liu, R., Chen, H., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113765 · Cited by 26
Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads
Leandro, K., Rufino‐Ramos, D., Breyne, K., Ianni, E. D., Lopes, S., Nobre, R. J., Kleinstiver, B. P., Perdigão, P. R. L., Breakefield, X. O., & de Almeida, L. P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115346 · Cited by 27
Self-citationDirected evolution expands CRISPR–Cas12a genome-editing capacity
Ma, E., Chen, K., Shi, H., Wasko, K. M., Esain-Garcia, I., Trinidad, M. I., Zhou, K., Ye, J., & Doudna, J. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf649 · Cited by 27
Steyer, B., Carlson-Stevermer, J., Angenent-Mari, N., Khalil, A. S., Harkness, T., & Saha, K. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.036 · Cited by 28
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing
Chadwick, A. C., & Musunuru, K. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0668-8 · Cited by 26
Multigene editing via CRISPR/Cas9 guided by a single‐sgRNA seed in Arabidopsis
Yu, Z., Chen, Q., Chen, W., Zhang, X., Mei, F., Zhang, P., Zhao, M., Wang, X., Shi, N., Jackson, S. D., et al. (2017) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12622 · Cited by 26
CRISPR/Cas therapeutic strategies for autosomal dominant disorders
Caruso, S. M., Quinn, P. M. J., da Costa, B. L., & Tsang, S. H. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158287 · Cited by 26
Singh, J., Sharma, D., Brar, G. S., Sandhu, K. S., Wani, S. H., Kashyap, R., Kour, A., & Singh, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07741-2 · Cited by 26
How to Completely Squeeze a Fungus—Advanced Genome Mining Tools for Novel Bioactive Substances
Schüller, A., Studt, L., & Strauss, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091837 · Cited by 26
Naeem, M., Alkhodairy, H. F., Ashraf, I., & Khalil, A. B. (2022) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-022-07266-7 · Cited by 27
Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense
Price, A. A., Grakoui, A., & Weiss, D. S. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.01.005 · Cited by 26
Genome Editing for the Study of Cardiovascular Diseases
Chadwick, A. C., & Musunuru, K. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0830-5 · Cited by 28
Fishing for understanding: Unlocking the zebrafish gene editor’s toolbox
Simone, B. W., Martínez‐Gálvez, G., WareJoncas, Z., & Ekker, S. C. (2018) · Methods · doi:10.1016/j.ymeth.2018.07.012 · Cited by 28
Targeting Specificity of the CRISPR/Cas9 System
Tasan, I., & Zhao, H. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00270 · Cited by 26
Engineering Cas9: next generation of genomic editors
Kovalev, M. A., Davletshin, A. I., & Karpov, D. S. (2024) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-024-13056-y · Cited by 29
Singh, S., Mishra, V., Riyazuddin, R., Chugh, V., & Upadhyay, S. K. (2024) · Plant Breeding · doi:10.1111/pbr.13234 · Cited by 27
Therapeutic genome engineering via CRISPR ‐Cas systems
Moreno, A. M., & Mali, P. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1380 · Cited by 25
Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools
Zhu, Y., & Huang, Z. (2018) · National Science Review · doi:10.1093/nsr/nwy150 · Cited by 26
Das, A., Hand, T. H., Smith, C. L., Wickline, E., Zawrotny, M., & Li, H. (2020) · Nature Communications · doi:10.1038/s41467-020-20204-1 · Cited by 25
Engineered dual selection for directed evolution of SpCas9 PAM specificity
Goldberg, G. W., Spencer, J. M., Giganti, D. O., Camellato, B. R., Agmon, N., Ichikawa, D. M., Boeke, J. D., & Noyes, M. B. (2021) · Nature Communications · doi:10.1038/s41467-020-20650-x · Cited by 29
CRISPR-Cas9 and beyond: what’s next in plant genome engineering
Zess, E. K., & Begemann, M. B. (2021) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-021-10185-1 · Cited by 25
Approaches to Enhance Precise CRISPR/Cas9-Mediated Genome Editing
Denes, C. E., Cole, A. J., Aksoy, Y. A., Li, G., Neely, G. G., & Hesselson, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168571 · Cited by 28
Escobar, M., Li, J., Patel, A., Liu, S., Xu, Q., & Hilton, I. B. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00156 · Cited by 25
Zhang, Z., Lamson, A., Shelley, M., & Troyanskaya, O. G. (2023) · Nature Computational Science · doi:10.1038/s43588-023-00569-1 · Cited by 26
Finnigan, G. C., & Thorner, J. W. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.029801 · Cited by 26
Periwal, V. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw052 · Cited by 25
System-level genome editing in microbes
Csörgő, B., Nyerges, Á., Pósfai, G., & Fehér, T. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.07.005 · Cited by 25
CRISPR editing in biological and biomedical investigation
Huang, J., Wang, Y., & Zhao, J. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26141 · Cited by 25
The use of CRISPR/Cas associated technologies for cell transplant applications
Cowan, P. J. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000347 · Cited by 24
Liu, J., & Shui, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.014 · Cited by 24
The multiplexed CRISPR targeting platforms
Cao, J. P., Xiao, Q., & Yan, Q. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.01.001 · Cited by 27
Versatile High-Throughput Fluorescence Assay for Monitoring Cas9 Activity
Seamon, K. J., Light, Y. K., Saada, E. A., Schoeniger, J. S., & Harmon, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01155 · Cited by 24
CRISPR/Cas9-Mediated Genome Editing for Huntington’s Disease
Vachey, G., & Déglon, N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7825-0_21 · Cited by 24
Breunig, C., Köferle, A., Neuner, A. M., Wiesbeck, M. F., Baumann, V., & Stricker, S. H. (2020) · Physiological Reviews · doi:10.1152/physrev.00034.2019 · Cited by 27
Hu, M., Cherkaoui, I., Misra, S., & Rutter, G. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.576632 · Cited by 24
Metadata
- Authors
- Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P. W., Li, Z., Peterson, R. T., Yeh, J.-R. J., Aryee, M. J., & Joung, J. K.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Broad Institute (US)
- Corresponding author
- Joung, J. Keith
- ORCID
- Venue
- Nature
- Published
- 2015-06-22
- Volume
- 523
- Issue
- 7561
- Pages
- 481-485
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4540238
- OpenAlex
- W4245053291
- Semantic Scholar
- afe29e1767b5d0f3563ee9f2c1a586a9d5e8cb9b
- Cited by
- 1,624
- References
- 36
- Citations by year
- 2026: 58 · 2025: 105 · 2024: 117 · 2023: 134 · 2022: 166 · 2021: 165 · 2020: 164 · 2019: 154 · 2018: 147 · 2017: 186 · 2016: 167 · 2015: 58
- FWCI
- 80.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of General Medical Sciences (DP1GM105378, R01GM107427, R01GM088040)
- National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, protospacer adjacent motif, genome editing, off-target effects, SaCas9, Cas9 nickase, zebrafish
- MeSH terms
- Animals, Cell Line, Humans, Mutation, Staphylococcus aureus, Streptococcus pyogenes, Substrate Specificity, Zebrafish, Protein Engineering, Genome, Directed Molecular Evolution, Amino Acid Substitution, Streptococcus thermophilus, Nucleotide Motifs, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
